PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Laboratory of Molecular Immunology, Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming, China.\', \'National Kunming High-level Biosafety Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Yunnan, China.\', \'Laboratory of Molecular Immunology, Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming, China; Department of Acute Infectious Diseases Control and Prevention, Yunnan Provincial Center for Diseases Control and Prevention, Kunming, China.\', \'Laboratory of Molecular Immunology, Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming, China. Electronic address: MolecularImmunology@imbcams.com.cn.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1549-9634(22)00013-210.1016/j.nano.2022.102527
?:hasPublicationType
?:journal
  • Nanomedicine : nanotechnology, biology, and medicine
is ?:pmid of
?:pmid
?:pmid
  • 35104670
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Recombinant VLPs empower RBM peptides showing no immunogenicity in native SARS-COV-2 protein to elicit a robust neutralizing antibody response.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35104670>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35104670>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all